부산대학교 도서관

van der Noord VE; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands. v.e.van.der.noord@lacdr.leidenuniv.nl.; McLaughlin RP; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands.; Karuntu JS; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands.; He J; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands.; Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Cancer Genomic Netherlands, Erasmus University Medical Center, Rotterdam, 3000 CA, The Netherlands.; Basnet SKC; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, 5000, Australia.; Long Y; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, 5000, Australia.; Diab SAH; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, 5000, Australia.; Tadesse S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, 5000, Australia.; Proost N; Preclinical Intervention Unit, Netherlands Cancer Institute, Mouse Clinic for Cancer and Aging (MCCA), Amsterdam, 1066 CX, The Netherlands.; van Gerwen B; Preclinical Intervention Unit, Netherlands Cancer Institute, Mouse Clinic for Cancer and Aging (MCCA), Amsterdam, 1066 CX, The Netherlands.; Siteur B; Preclinical Intervention Unit, Netherlands Cancer Institute, Mouse Clinic for Cancer and Aging (MCCA), Amsterdam, 1066 CX, The Netherlands.; van de Ven M; Preclinical Intervention Unit, Netherlands Cancer Institute, Mouse Clinic for Cancer and Aging (MCCA), Amsterdam, 1066 CX, The Netherlands.; Pont C; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands.; Le Dévédec SE; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Cancer Genomic Netherlands, Erasmus University Medical Center, Rotterdam, 3000 CA, The Netherlands.; Wang S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, 5000, Australia.; Zhang Y; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands.; van de Water B; Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, 2300 RA, The Netherlands. b.water@lacdr.leidenuniv.nl.

Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Electronic Cited Medium: Internet ISSN: 2211-3436 (Electronic) Linking ISSN: 22113428 NLM ISO Abbreviation: Cell Oncol (Dordr) Subsets: MEDLINE

Isebia KT; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; de Jong AC; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; van Dessel LF; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; de Weerd V; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Beaufort C; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Helmijr J; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Nakauma-González JA; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; van Riet J; Division of AI in Oncology, German Cancer Research Center (DFKZ), Heidelberg, Germany.; Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Vis D; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Beije N; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Lolkema MP; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Deger T; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Wilting SM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; de Wit R; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Jansen MPHM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, University Medical Center Rotterdam, The Netherlands.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Stevens M; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; FETCH BV, Deventer, The Netherlands.; Mentink A; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; Coumans FAW; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; Decisive Science, Amsterdam, The Netherlands.; Dathathri E; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Terstappen LWMM; Department of Medical Cell BioPhysics, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.; Decisive Science, Amsterdam, The Netherlands.; Department of General, Visceral and Pediatric Surgery, University Hospital Düsseldorf, Germany.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Helmijr, Jean; Motta, Gianmarco; Jongbloed, Lisa; de Weerd, Vanja; van Bergen, Lotte; Verschoor, Noortje; Stella, Stefania; Beaufort, Corine; Vigneri, Paolo; Martens, John W M; Wilting, Saskia M; Jansen, Maurice P H M

The Journal of Applied Laboratory Medicine. 9:913-925

Robbrecht DGJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: d.robbrecht@erasmusmc.nl.; Salhi Y; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Aarts MJB; Department of Medical Oncology, GROW-School for Oncology and Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands.; Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland Hospital, Rotterdam/Schiedam, The Netherlands.; van der Heijden MS; Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; Voortman J; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; de Wit R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Boormans JL; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Nakauma-González JA; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Huang Z; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Beaufort C; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Helmijr J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Zantboer B; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Rozema G; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Muritti C; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Whien JJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Uijterwegen A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Massimino M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Department of General Surgery and Medical-Surgical Specialties, University of Catania, 95124 Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico-S. Marco', 95123 Catania, Italy.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.; Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

van Geel JJL; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; Jongbloed EM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Moustaquim J; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Schoor G; Dutch Breast Cancer Research Group (BOOG), Utrecht, The Netherlands.; van Leeuwen-Stok AE; Dutch Breast Cancer Research Group (BOOG), Utrecht, The Netherlands.; Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; van Deurzen CHM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Wesseling J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Divisions of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands. c.schroder@nki.nl.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. c.schroder@nki.nl.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Lin AY; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Isaeva OI; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Deger T; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Geurts VCM; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Vessies DCL; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Voorwerk L; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, the Netherlands.; Slagter M; Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Moore KS; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Leest P; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands.; van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Wessels LFA; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kok M; Division of Tumor Biology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.kok@nki.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Schreurs MAC; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Timmermans AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Carpenter MA; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, 78229, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, Texas, 78229, USA.; Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; den Bakker MA; Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands.; van Deurzen CHM; Department of Pathology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.; Harris RS; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, Texas, 78229, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, Texas, 78229, USA.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. j.martens@erasmusmc.nl.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE; In Process

Jongbloed EM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Wortelboer N; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Ruigrok-Ritstier K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Van MN; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; van Zweeden AA; Department of Medical Oncology, Amstelland Hospital, Amstelveen, the Netherlands.; van der Padt-Pruijsten A; Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands.; Hamming LC; Department of Medical Oncology, Frisius MC Leeuwarden, Leeuwarden, the Netherlands.; Konings IR; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.; Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. s.wilting@erasmusmc.nl.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Bos MK; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Starmans MPA; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Helmijr JCA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; De Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Joosse A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Castro-Mondragon, Jaime A; Aure, Miriam Ragle; Lingjærde, Ole Christian; Langerød, Anita; Martens, John W M; Børresen-Dale, Anne-Lise; Kristensen, Vessela N; Mathelier, Anthony

Nucleic Acids Research; 11/28/2022, Vol. 50 Issue 21, p12131-12148, 18p

Wullaert L; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Meyer YM; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Voigt K; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Makrodimitris S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Van M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Vermaas M; Department of Surgical Oncology and Gastrointestinal Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands.; Belt EJT; Department of Surgical Oncology and Gastrointestinal Surgery, Albert Schweitzer Hospital, Dordrecht, the Netherlands.; Gobardhan PD; Department of Surgical Oncology and Gastrointestinal Surgery, Amphia Hospital, Breda, the Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Grünhagen DJ; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE

Dathathri E; Department of Medical Cell Biophysics, Technical Medical Center, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.; Abali F; Department of Medical Cell Biophysics, Technical Medical Center, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.; Stevens M; Department of Medical Cell Biophysics, Technical Medical Center, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.; VYCAP, Enschede, the Netherlands.; Booijink R; Department of Medical Cell Biophysics, Technical Medical Center, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.; van Dijk TC; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Isebia KT; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Beije N; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Amgen, Thousand Oaks, California.; Te Boekhorst PAW; Department of Hematology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, the Netherlands.; Haberkorn BCM; Department of Medical Oncology, Maasstad Hospital, Rotterdam, the Netherlands.; Houtsma D; Department of Internal Medicine, Haga Hospital, The Hague, the Netherlands.; van den Bosch J; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.; van der Deure WM; Department of Medical Oncology, Groene Hart Hospital, Gouda, the Netherlands.; Bansal R; Department of Medical Cell Biophysics, Technical Medical Center, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.; Terstappen LWMM; Department of Medical Cell Biophysics, Technical Medical Center, Faculty of Science and Technology, University of Twente, Enschede, the Netherlands.; Department of General, Visceral and Pediatric Surgery, Heinrich-Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Knol JC; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Lyu M; School of Medicine, Westlake University, Hangzhou, Zhejiang, China; Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.; Böttger F; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Nunes Monteiro M; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Pham TV; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Rolfs F; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Vallés-Martí A; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Schelfhorst T; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; de Goeij-de Haas RR; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Bijnsdorp IV; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Urology, De Boelelaan 1117, Amsterdam, the Netherlands.; Wang S; School of Medicine, Westlake University, Hangzhou, Zhejiang, China; Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.; Zhang F; School of Medicine, Westlake University, Hangzhou, Zhejiang, China.; A J; School of Medicine, Westlake University, Hangzhou, Zhejiang, China; Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.; Westerman BA; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurosurgery, De Boelelaan 1117, Amsterdam, the Netherlands.; Sitek B; Medizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany; Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.; Lehtiö J; Department of Oncology-Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.; Koster J; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; IJzermans JNM; Department of Surgery, Division of HPB & Transplant Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; van Laarhoven HWM; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Meibergdreef 9, Amsterdam, the Netherlands.; Bijlsma MF; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands.; Medema JP; Amsterdam UMC location University of Amsterdam, Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Meibergdreef 9, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Oncode Institute, Amsterdam, the Netherlands.; Henneman AA; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Piersma SR; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.; Brakenhoff RH; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Otolaryngology and Head and Neck Surgery, De Boelelaan 1117, Amsterdam, the Netherlands.; Cloos J; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Hematology, De Boelelaan 1117, Amsterdam, the Netherlands.; Cordo' V; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.; de Jong D; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, the Netherlands; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; HOVON Pathology Facility and Biobank, Amsterdam, the Netherlands.; Kazemier G; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Surgery, De Boelelaan 1117, Amsterdam, the Netherlands.; Koppers-Lalic D; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurosurgery, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Labots M; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Medical Oncology, De Boelelaan 1117, Amsterdam, the Netherlands.; Le Large TYS; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Surgery, De Boelelaan 1117, Amsterdam, the Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.; Meijerink JPP; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Mumtaz M; School of Biological Sciences, University of the Punjab, Lahore, Pakistan.; Scheepbouwer C; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurosurgery, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, the Netherlands.; Kibbelaar RE; on behalf of the HemoBase Consortium (www.hemobase.eu); Department of Pathology, Pathology Friesland, Leeuwarden, the Netherlands.; Noske DP; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Neurosurgery, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Steenbergen RDM; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, the Netherlands.; van Grieken NCT; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Pathology, De Boelelaan 1117, Amsterdam, the Netherlands.; van Houdt W; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Giovannetti E; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands; Amsterdam UMC location Vrije Universiteit Amsterdam, Department of Medical Oncology, De Boelelaan 1117, Amsterdam, the Netherlands.; van Leenders GJLH; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Jonkers J; Oncode Institute, Amsterdam, the Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Liu T; Department of Breast Surgery, Harbin Medical University, Harbin, China.; Yan M; Department of Pathology, Harbin Medical University, Harbin, China.; Zhan X; Harbin Medical University Cancer Hospital, Harbin, China.; Guo T; School of Medicine, Westlake University, Hangzhou, Zhejiang, China; Westlake Center for Intelligent Proteomics, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China. Electronic address: guotiannan@westlake.edu.cn.; Jimenez CR; Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of Medical Oncology, OncoProteomics Laboratory, De Boelelaan 1117, Amsterdam, the Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands. Electronic address: c.jimenez@amsterdamumc.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Massimino M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico - S. Marco', Catania, Italy.; Huang Z; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Helmijr J; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Muritti C; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Uijtdewillegen A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Vigneri P; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.; Center of Experimental Oncology and Hematology, A.O.U. Policlinico 'G. Rodolico - S. Marco', Catania, Italy.; Division of Oncology, Humanitas Istituto Clinico Catanese, 95045, Misterbianco, Catania, Italy.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. m.p.h.m.jansen@erasmusmc.nl.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Mulder CV; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jongbloed EM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Makrodimitris S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.; Hazelaar DM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Beaufort CM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; de Weerd V; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Mulder L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van Deurzen CHM; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.; Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Jansen MPHM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. e.lips@nki.nl.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Ju, Young Seok; Tubio, Jose M C; Mifsud, William; Fu, Beiyuan; Davies, Helen R; Ramakrishna, Manasa; Li, Yilong; Yates, Lucy; Gundem, Gunes; Tarpey, Patrick S; Behjati, Sam; Papaemmanuil, Elli; Martin, Sancha; Fullam, Anthony; Gerstung, Moritz; Nangalia, Jyoti; Green, Anthony R; Caldas, Carlos; Borg, Åke; Tutt, Andrew; Lee, Ming Ta Michael; Van't Veer, Laura J; Tan, Benita K T; Aparicio, Samuel; Span, Paul N; Martens, John W M; Knappskog, Stian; Vincent-Salomon, Anne; Børresen-Dale, Anne-Lise; Eyfjörd, Jórunn Erla; Flanagan, Adrienne M; Foster, Christopher; Neal, David E; Cooper, Colin; Eeles, Rosalind; Lakhani, Sunil R; Desmedt, Christine; Thomas, Gilles; Richardson, Andrea L; Purdie, Colin A; Thompson, Alastair M; McDermott, Ultan; Yang, Fengtang; Nik-Zainal, Serena; Campbell, Peter J; Stratton, Michael R; ICGC Prostate Cancer Working Group; ICGC Bone Cancer Working Group; ICGC Breast Cancer Working Group

Genome Research. 25(6):814-824

Hoogstrate, Youri; Komor, Malgorzata A; Böttcher, René; van Riet, Job; van de Werken, Harmen J G; van Lieshout, Stef; Hoffmann, Ralf; van den Broek, Evert; Bolijn, Anne S; Dits, Natasja; Sie, Daoud; van der Meer, David; Pepers, Floor; Bangma, Chris H; van Leenders, Geert J L H; Smid, Marcel; French, Pim J; Martens, John W M; van Workum, Wilbert; van der Spek, Peter J

GigaScience. Dec2021, Vol. 10 Issue 12, p1-16. 16p.

Verschoor N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. n.verschoor@erasmusmc.nl.; Bos MK; Department of Internal Medicine, Breast Cancer Center South Holland South, Ikazia Hospital, Rotterdam, The Netherlands.; de Kruijff IE; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Van MN; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Drooger JC; Department of Internal Medicine, Breast Cancer Center South Holland South, Ikazia Hospital, Rotterdam, The Netherlands.; Zuetenhorst JM; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, The Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE